Europe Smart Insulin Pens Market Research Report: Forecast (2025-2030)

Market Definition

The Smart Insulin Pens are technologically advanced insulin delivery devices that can be integrated with a mobile application via NFC or Bluetooth to provide a digital log of insulin usage and provide features such as a dosage tracker, reminder, and analysis to help patients manage their insulin on their own.

Market Insights & Analysis: Europe Smart Insulin Pens Market (2025-30):

The Europe Smart Insulin Pens Market size was valued at around USD 109 million in 2024 and is projected to reach USD 223 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 12.21% during the forecast period, i.e., 2025-30. Major market growth drivers consist of rising diabetes prevalence and increasing inclination toward remote monitoring and digital health. Furthermore, Europe is highly impacted by the ever-increasing old-age population. The Organization for Economic Co-operation and Development (OECD) report from 2024 anticipates an incremental increase from 21% over the year 2023 to 29% in 2030 for the over 65 years of age population. This again nudges the growth prospects of the smart insulin pens market since chronic conditions like diabetes are quite frequently encountered in older populations, as advocated by multiple healthcare reports.

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Besides, there is a soaring preference for minimally invasive and convenient insulin delivery devices, which is consequently triggering the demand for smart insulin pens as they offer pain-free and convenient delivery of insulin the patients.

Another factor that has impacted the growth of these pens in Europe is the acute shortage of healthcare staff in the region. OECD published data in 2024, which reported that during 2022 and 2023, 20 countries in Europe reported a shortage of health workforce, including doctors and nurses. This shortage of medical staff limits the proper monitoring and treatment of such a huge mass of patients suffering from various severe diseases. Such a situation is encouraging chronic disease patients, like diabetes, to self-manage their disease at home. Self-management of diabetes by patients at home is boosting the demand for smart insulin pens, helping to reduce dependence on doctors.

Europe Smart Insulin Pens Market Driver:

Increasing Occurrence of Diabetes Driving Market Growth – The region has registered a considerable growth in diabetic prevalence in the past decade. According to the World Health Organization (WHO), in 2021, at least 64 million adults and 300,000 children, and adolescents were suffering from diabetes. Moreover, this number for adults is anticipated to increase to 69 million by 2045.

Poor dietary habits of Europeans, coupled with insufficient physical exercise and extreme work and social stress, are major contributors to the surging occurrence of diabetes. Diabetes is also registering a spike owing to several genetic mutations, hormonal disorders, etc. Owing to the spike in the number of diabetes patients, consumers are inclining towards smart insulin pens to manage their diabetes at home, as the device is convenient, cost-effective, and provides efficient insulin delivery. The increasing disposable income is allowing consumers in the region to spend on smart healthcare devices.

The smart technology built into these pens allows patients to keep a routine track of their doses, along with getting reminders and personalized analysis of their history of doses. A proper track of insulin dosages and their regular intake helps in improving blood sugar levels. As the diabetes is well managed, the risk of severe fluctuations of blood glucose level reduces, thereby reducing the chance of hospitalization or sudden deaths due to diabetes. Hence, the demand for the smart insulin pen market will also increase in the forecast period and beyond.

Europe Smart Insulin Pens Market Opportunity:

Government Initiatives for Detecting Undiagnosed Diabetic Population – Government Initiatives for the Detection of the Undiagnosed Diabetic Population in the region are the factors offering growth opportunities to the market. For instance, the European Government initiated a 5-year project in 2023 for the diagnosis of early non-clinical Type 1 diabetes for disease interception. The project will include a screening of 200,000 children and adolescents in Europe. It will assess the economic, psychological, and medical impact of population screening and build a roadmap for better diagnosis and treatment for Type 1 diabetes. The project will end in 2028.

According to WHO, over 1 in 3 adults (around 36%) living with diabetes are undiagnosed. Such Pan-Europe initiatives will result in the accurate detection of populations that have newly acquired or were unaware of their diabetes, offering a new market for insulin pen manufacturers to target. This will result in immense market growth opportunities for smart pen manufacturers.

Europe Smart Insulin Pens Market Challenge:

High Cost of Smart Pens Restraining the Market Growth – The new smart insulin pens are technologically advanced and highly innovative, which is why the prices of these pens are also significantly high. The price of smart insulin pens ranges between USD 500 to USD 900, while traditional insulin pens range below USD 100. This huge cost difference creates a barrier for the growth of the market as it restricts, particularly, the uninsured people from product adoption. Even people with insurance find it difficult to make such an expensive purchase, as coverage of smart insulin pens in medical insurance is either limited or not provided. Thus, the limited product adoption due to its high price eventually hampers the market growth.

 Europe Smart Insulin Pens Market Trend:

Technological Advancements Adding New Capabilities to Smart Insulin Pens – Manufacturers of smart insulin pens are researching and developing the latest technologies to integrate into smart pens to enhance their efficiency. Among them, Bluetooth technology is the most popular and highly adopted one. Integration of Bluetooth in smart pens has instantly increased their relevance, as Bluetooth allows linking of smart pens with any smartphone, allowing access to the insulin delivery information to the user. Moreover, the addition of artificial intelligence capabilities further boosts the pens’ performance and functionalities.

Artificial intelligence will eventually enhance blood glucose data analysis and provide personalized alerts and recommendations for doses that fit activity patterns, mealtime, and insulin doses. Some smart insulin pens also work with continuous glucose monitors (CGMs), such as Dexcom and FreeStyle Libre systems, to provide recommendations for insulin dosing. In Europe, Dexcom CGM will soon be compatible with smart insulin pens, such as the NovoPen 6 and NovoPen Echo Plus, to facilitate better diabetes management to the benefit of patients in countries such as Germany, the UK, and Spain. The market players are making continuous efforts to integrate advanced AI and IoT in their products. A combination of such technologies will continue to bring immense potential to the smart pens and will aid in increasing the market growth.

Europe Smart Insulin Pens Market (2025-30): Segmentation Analysis

The Europe Smart Insulin Pens Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment. It includes predictions for the period 2025-2030 at the regional level. Based on the analysis, the market has been further classified as:

Based on Application:

• Type 1 Diabetes
• Type 2 Diabetes

Based on the application, the market is segmented into Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D) categories. Type 1 Diabetes is dominating the European Smart Insulin Pen Market with a market share of around 70%. Patients with type 1 diabetes completely rely on insulin doses, as without these external doses, the levels of blood sugar cannot be maintained. Unmanaged diabetes might lead to a life-threatening condition. On the other hand, patients living with type 2 diabetes can manage their blood sugar with regular exercise and medicines. Extreme and severe cases of T2D sometimes require insulin external injection. Thus, smart insulin pens attract higher demand from the T1D segment.

Type 1 diabetes is not only common among adults but also among children and adolescents. According to WHO, in 2021, Europe had the highest burden of type 1 diabetes, which was anticipated to continue to hold the same level in the coming years. The significant reliance of T1D patients on external insulin doses is since their bodies do not generate natural insulin, and they require an injection of insulin. Mostly, such patients take more than 1 dose, although it varies based on their day-to-day activities and food intake. Multiple doses, if taken through injections, will cause discomfort and missed or duplicate injections. Thus, people are inclining towards the adoption of smart pens as they provide precision, accurate doses, convenience, and proper tracking of doses. These benefits are driving the demand for smart insulin pens in the T1D segment.

Based on Connectivity:

• Bluetooth
• Near Field Communication (NFC)

Among these, the Bluetooth segment holds the largest share. The segment holds a market share of around 68%. This growth is augmented by the convenience and higher efficiency offered by Bluetooth connectivity. The Bluetooth functionality offers real-time, automatic data syncing, making them more suitable for continuous tracking & CGM integration. Hence, people looking for convenient connectivity options prefer Bluetooth smart insulin pens, thereby increasing the demand for these pens in the coming years.

Additionally, the Near Field Communication (NFC) holds a lower market size in comparison to the Bluetooth segment. This is owing to several limitations in NFC connectivity, such as manual scanning (tapping) on a smartphone to sync data, limited integration with CGMs, and no live alerts, data updates when scanned, while the Bluetooth insulin pens have these capabilities. Thus, NFC-integrated insulin pens are suitable for those who don’t need real-time tracking.

Europe Smart Insulin Pens Market (2025-30): Regional Projections

Geographically, the Europe Smart Insulin Pens Market expands across:

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

The Smart Insulin Pens Market is expanding across European countries, with Germany holding the highest market share. Germany held around 18% of the total market in 2024. The Smart Insulin Pen Market in Europe presents a strong growth in Germany owing to a significant factor, that is, soaring diabetes incidences. The Central Research Institute of Ambulatory Health Care in Germany (Zi) published that the number of diabetic patients increased from 6.19 million in 2021 to 8.9 million in 2023.

Additionally, the growing healthcare expenditure in the country also backs the growth of smart insulin pens in the country. As per the International Diabetes Federation's published data, Germany’s healthcare expenditure related to diabetes is anticipated to increase from USD 41,295.80 million in 2021 to USD 42,364.90 million by 2030. The numbers depict the financial capability of Germans to spend on advanced treatments for diabetes. Moreover, the increasing geriatric population will also influence the growth of the market as the older population is more vulnerable to diabetes occurrence. All these factors contribute significantly to creating the dominance of Germany in the Europe Smart Insulin Pens Market in 2024, and will also surge the demand in the forecasted period.

Europe Smart Insulin Pens Industry Recent Development:

• 2024: Medtronic received FDA clearance for its new InPen™ app, which includes missed meal dose detection. This approval supports the launch of its Smart MDI system, which integrates the InPen™ smart insulin pen with the Simplera™ CGM.
• 2023: Diabeloop announced a collaboration with Novo Nordisk. The agreement covers integrating DBL-4penTM, Diabeloop’s self-learning algorithm for MDI therapy, with Novo Nordisk’s connected and reusable insulin pens, NovoPen® 6 and NovoPen Echo® Plus.

Gain a Competitive Edge with Our Europe Smart Insulin Pens Market Report

1. Europe Smart Insulin Pens Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. Europe Smart Insulin Pens Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.